http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18089890

Outgoing Links

Predicate Object
contentType Comparative Study|Evaluation Study|Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 108
issn 1875-8592
1574-0153
issueIdentifier 2
pageRange 101-108
publicationName Cancer biomarkers : section A of Disease markers
startingPage 101
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a11902aefba33115eaf397413bf11ceb
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0c9c0483b9151639764bfaa845d8f5bf
bibliographicCitation Kohli M, Rothberg PG, Feng C, Messing E, Joseph J, Rao SS, Hendershot A, Sahsrabudhe D. Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer. Cancer Biomark. 2010;7(2):101–8. PMID: 21178268; PMCID: PMC3982319.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3afb7b2c63e92697895c9c90b57eb0cc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ad80ff559db6ee4d05272fb8bcbebc3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9735-6614
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_886e31767a1eab567fe6a944fb64ca66
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14e5f05dc42a5afd033c05f40738bd90
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d515c599569c079bab5a31003558ac9c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d292170216ab9ce3745596501f4262fa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e59e4873f2b6ab7ff6c76f5c95055abe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1ea7db9bae681c6c2cf3ef7facf2347
date 2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC3982319
https://pubmed.ncbi.nlm.nih.gov/21178268
https://doi.org/10.3233/cbm-2010-0152
isPartOf https://portal.issn.org/resource/ISSN/1574-0153
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33183
https://portal.issn.org/resource/ISSN/1875-8592
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer
discusses http://id.nlm.nih.gov/mesh/M0009130
http://id.nlm.nih.gov/mesh/M0328361
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D011471Q000097
http://id.nlm.nih.gov/mesh/D020641
http://id.nlm.nih.gov/mesh/D011471Q000235
http://id.nlm.nih.gov/mesh/D020840Q000235
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D012008
http://id.nlm.nih.gov/mesh/D005838
http://id.nlm.nih.gov/mesh/D000483
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D020840Q000097
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D005819
http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b97f959a98ee690070b0d472ca3a6817
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3817

Total number of triples: 55.